Culture
J&J to buy Halda Therapeutics in US$3.05 billion cash deal
Johnson & Johnson has agreed to buy the cancer treatment biotech Halda Therapeutics for US$3.05 billion cash, part of a strategy to cope…
Tag
Johnson & Johnson has agreed to buy the cancer treatment biotech Halda Therapeutics for US$3.05 billion cash, part of a strategy to cope…
The company’s technology is used to create analgesic products that can aid patients with post-surgical pain management and recuperation…
SWITZERLAND’S Roche will acquire its US collaboration partner Poseida Therapeutics in a cash deal worth up to US$1.5 billion, banking on…